Buy Rossari Biotech; target of Rs 860: Deven Choksey

Deven Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 860 in its research report dated July 25, 2025.

Broker Research

July 25, 2025 / 12:42 IST

buy

26 Aug, 2025 12:21

Volume

Todays L/H

Deven Choksey's research report on Rossari Biotech

Rossari Biotech’s Q1FY26 revenue grew by 11.0% YoY (-6.2% QoQ) to INR 5,437 Mn., in-line with our estimates, the growth was entirely driven by volume expansion of 11.0% YoY. The performance was supported by robust momentum across HPPC and AHN segments, partially offset by continued weakness in the TSC vertical. Although, both domestic and export markets delivered growth (YoY), sequential softness was observed in exports, reflecting near-term global headwinds.

Outlook

We have rolled forward our valuation basis to Jun’27 estimates. We value Rossari Biotech at a 23.0x Jun’27 EPS, implying a target price of INR 860, supported by strong momentum in HPPC and AHN segments and improving breakeven trajectory in the institutional business. We reiterate our “BUY” rating on the stock.

For all recommendations report, click here